Relationship Between Hypoxia and Endocrine Response in Human Breast Cancer
Status:
Unknown status
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The aim of our current study was to analyze whether 18F-labeled Fluoromisonidazole
(1-(2-nitro-1-imidazolyl)- 2-hydroxy-3-fluoropropane [18F-FMISO]) PET/CT and expression of
HIF-1-alpha could predict response of primary endocrine therapy in ER-positive breast cancer